Pharma Reviews: Indian pharma to hit double-digit growth on US sales, weak rupee: CRISIL

The return to double-digit growth would help the homegrown pharma companies, with turnover of Rs 10 billion or more, to weather a sharp rise in ...
Read more: Indian pharma to hit double-digit growth on US sales, weak rupee: CRISIL